NumFin

Nanjing Vishee Medical Technology Co., Ltd

符号: 688580.SS

SHH

47.44

CNY

今天的市场价格

  • 25.8198

    市盈率

  • 0.0000

    PEG比率

  • 3.23B

    MRK市值

  • 0.01%

    DIV收益率

Nanjing Vishee Medical Technology Co., Ltd (688580-SS) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Nanjing Vishee Medical Technology Co., Ltd (688580.SS). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Nanjing Vishee Medical Technology Co., Ltd 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620142013

balance-sheet.row.cash-and-short-term-investments

011551248.11366
1366.5
244.4
162.2
135.4
93.5
11.7
7.9

balance-sheet.row.short-term-investments

02266.400
0
0
0
0
0
0
-0.6

balance-sheet.row.net-receivables

047.331.936.7
14.5
4.7
1.4
2.5
3
7.1
8.4

balance-sheet.row.inventory

039.934.830.4
37.1
31.5
20
14.2
9.4
7.5
12.2

balance-sheet.row.other-current-assets

012.64.31.2
0.8
1.8
1.8
1
0.3
40.3
38.3

balance-sheet.row.total-current-assets

01254.81319.21434.3
1418.9
282.3
185.4
153.1
106.2
66.6
66.8

balance-sheet.row.property-plant-equipment-net

0321.5172.5100.3
98.3
101.3
102.5
70.1
49.9
1.9
0.7

balance-sheet.row.goodwill

069.369.30
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0120.6106.518.8
20
19.2
19.8
21.4
11.4
12
0.9

balance-sheet.row.goodwill-and-intangible-assets

0189.9175.818.8
20
19.2
19.8
21.4
11.4
12
0.9

balance-sheet.row.long-term-investments

0-2244.300.8
1.1
-1.1
0
0
0
0
0.8

balance-sheet.row.tax-assets

015.17.912.7
2.1
1
0.6
1.7
2
0
0.2

balance-sheet.row.other-non-current-assets

022698.871.9
0.2
1.3
0
0.2
0.3
0.8
2.2

balance-sheet.row.total-non-current-assets

0551.2365204.4
121.6
121.9
122.9
93.5
63.5
14.7
4.7

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0

balance-sheet.row.total-assets

018061684.21638.7
1540.4
404.2
308.4
246.6
169.7
81.3
71.5

balance-sheet.row.account-payables

01819.79.3
9.9
10.5
7.8
8.4
5.8
1
3.6

balance-sheet.row.short-term-debt

001.21.2
1.1
10
5.5
0.5
0
0
0

balance-sheet.row.tax-payables

019.621.129.3
22.7
15.4
6.7
7.2
6.9
2.2
2.3

balance-sheet.row.long-term-debt-total

0001.8
3
4
14
19.5
0
0
0

Deferred Revenue Non Current

0000
0.8
3.7
3.7
2.3
1.5
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0133.794.81.6
55
71
81.2
62.4
44.2
18.7
29.1

balance-sheet.row.total-non-current-liabilities

027.626.41.8
0.8
7.7
17.7
21.8
1.5
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

001.21.8
3
0
0
0
0
0
0

balance-sheet.row.total-liab

0179.3155.7105.7
129.5
149.4
112.2
93.1
51.5
19.7
32.7

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0

balance-sheet.row.common-stock

068.668.668.3
68.3
51.3
51.3
51.3
50
10
5.2

balance-sheet.row.retained-earnings

0438.4349.1344.3
238.3
153.4
101.5
64.6
52.6
50.3
32.9

balance-sheet.row.accumulated-other-comprehensive-income-loss

01588.934.858.1
34.2
25.3
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0-469.210761062.3
1065.2
19.3
34.6
28.2
15.6
0.7
0

balance-sheet.row.total-stockholders-equity

01626.81528.51533.1
1406
249.2
187.4
144.1
118.2
60.9
38.1

balance-sheet.row.total-liabilities-and-stockholders-equity

018061684.21638.7
1540.4
404.2
308.4
246.6
169.7
81.3
71.5

balance-sheet.row.minority-interest

0000
5
5.6
8.7
9.4
0
0.7
0.7

balance-sheet.row.total-equity

01626.81528.51533.1
1411
254.9
196.2
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-

Total Investments

02200.8
1.1
-1.1
0
0
0.2
0.4
0.2

balance-sheet.row.total-debt

001.23
4.2
14
19.5
20
0
0
0

balance-sheet.row.net-debt

0-1155-1246.9-1363
-1362.3
-230.4
-142.7
-115.4
-93.5
-11.7
-7.9

现金流量表

在 Nanjing Vishee Medical Technology Co., Ltd 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620142013

cash-flows.row.net-income

093.8177.5143.1
98.9
62.7
40.2
23.1
21.8
14.3

cash-flows.row.depreciation-and-amortization

017.111.18.8
8
3.8
0.8
0.7
0.7
0.6

cash-flows.row.deferred-income-tax

02.3-8.1-1.1
-0.4
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-2.821.41.1
0.4
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-8.7-33.5-19.1
37.8
21.8
9.1
7
-3.6
-6

cash-flows.row.account-receivables

07.3-13.1-15.9
-2.5
0
0
0
0
0

cash-flows.row.inventory

01.86.7-5.6
-11.6
-5.8
-5.3
-1.3
4.7
-1.8

cash-flows.row.account-payables

0-20.1-193.4
52.3
0
0
0
0
0

cash-flows.row.other-working-capital

02.3-8.1-1.1
-0.4
27.6
14.5
8.2
-8.3
-4.2

cash-flows.row.other-non-cash-items

0-15.6-11-12.1
-3.2
-2.5
2.2
0.2
-3.8
-0.6

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-95.6-87.3-11.7
-21.2
-40.9
-14.5
-17.4
-10.9
-2.5

cash-flows.row.acquisitions-net

0-34.2011.7
21.2
0
0
17.4
0
0

cash-flows.row.purchases-of-investments

0-3648-4264-2102.4
-1191.7
-781.5
-550.7
-515.7
-226.9
-115.6

cash-flows.row.sales-maturities-of-investments

036644284.62115.8
1196
784.9
552.6
522.8
226.2
100

cash-flows.row.other-investing-activites

09-10-11.7
-21.2
0
0
-17.4
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-104.8-76.81.9
-16.9
-37.5
-12.7
-10.3
-11.6
-18.1

cash-flows.row.debt-repayment

0-2-1.3-14
-5.5
-0.5
0
0
0
0

cash-flows.row.common-stock-issued

016.9-0.3-18
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0-14.91.618
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-88.9-71.8-50.3
-34.6
-21
-24.5
-8.4
-4.4
-2.5

cash-flows.row.other-financing-activites

0-6.1-9.21059.1
-2.4
0
26.8
0
4.8
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0-95-81994.8
-42.4
-21.5
2.3
-8.4
0.4
-2.5

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-113.6-0.41117.4
82.1
26.8
41.9
12.3
3.8
-12.4

cash-flows.row.cash-at-end-of-period

01247.71361.31361.7
244.4
162.2
135.4
93.5
11.7
7.9

cash-flows.row.cash-at-beginning-of-period

01361.31361.7244.4
162.2
135.4
93.5
81.2
7.9
20.3

cash-flows.row.operating-cash-flow

086.2157.4120.8
141.5
85.8
52.3
31
15
8.2

cash-flows.row.capital-expenditure

0-95.6-87.3-11.7
-21.2
-40.9
-14.5
-17.4
-10.9
-2.5

cash-flows.row.free-cash-flow

0-9.470109.1
120.2
44.9
37.8
13.6
4.1
5.7

利润表行

Nanjing Vishee Medical Technology Co., Ltd 的收入与上期相比变化了 NaN%。据报告, 688580.SS 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620142013

income-statement-row.row.total-revenue

0462.2321.6430
378.4
318.9
207.8
144.5
95.9
58.2
48.9

income-statement-row.row.cost-of-revenue

0130.588.5108.5
99.8
83.8
53.7
37.9
25.6
17.3
15.3

income-statement-row.row.gross-profit

0331.7233.1321.6
278.6
235.1
154.1
106.6
70.4
40.8
33.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

01.6187.4
13
11.9
3.7
-0.5
6.6
5.4
7.2

income-statement-row.row.operating-expenses

0208.7162.9163.1
132.4
123.9
84.9
61.2
52.1
27.8
26.7

income-statement-row.row.cost-and-expenses

0339.2251.4271.6
232.2
207.7
138.6
99.1
77.6
45.2
42

income-statement-row.row.interest-income

019.319.316.8
6.4
0.2
0.2
0.2
-0.1
0
0

income-statement-row.row.interest-expense

01.30.30.2
0.4
0.9
0.6
-0.2
-0.1
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

01.61.42.7
1.2
0.1
1.3
-0.1
8.7
5.4
7.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

01.6187.4
13
11.9
3.7
-0.5
6.6
5.4
7.2

income-statement-row.row.total-operating-expenses

01.61.42.7
1.2
0.1
1.3
-0.1
8.7
5.4
7.2

income-statement-row.row.interest-expense

01.30.30.2
0.4
0.9
0.6
-0.2
-0.1
0
0

income-statement-row.row.depreciation-and-amortization

020.119.514.9
11.2
9.1
5.8
0.1
0.7
0.7
0.6

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0148.4104.5194.7
164.9
114.7
72
46.8
20.3
17.1
7.7

income-statement-row.row.income-before-tax

0150105.8197.4
166.1
114.8
73.4
46.7
26.9
22.5
14.9

income-statement-row.row.income-tax-expense

013.81219.8
22.9
15.9
10.6
6.5
3.8
0.8
0.6

income-statement-row.row.net-income

0136.393.8177.8
143.7
99.7
63.4
40.3
23.1
21.7
14
类似股票
您可能还对以下内容感兴趣：
EW
Edwards Lifesciences Corporation.
87.42 USD
NYSE
SOFW.TA
SofWave Medical Ltd..
1778 ILA
TLV
BIOL
BIOLASE, Inc..
0.1739 USD
NASDAQ
4549.T
Eiken Chemical Co., Ltd..
2002 JPY
JPX
USAQ
QHSLab, Inc..
0.08685 USD
PNK
QLIFE.ST
Qlife Holding AB (publ).
0.003 SEK
STO
VITR.ST
Vitrolife AB (publ).
178.2 SEK
STO
LFWD
ReWalk Robotics Ltd..
5.16 USD
NASDAQ
BBLG
Bone Biologics Corporation.
1.8001 USD
NASDAQ
300298.SZ
Sinocare Inc..
23.32 CNY
SHZ
HYPR
Hyperfine, Inc..
0.7971 USD
NASDAQ

常见问题

什么是 Nanjing Vishee Medical Technology Co., Ltd (688580.SS) 总资产是多少？

Nanjing Vishee Medical Technology Co., Ltd (688580.SS) 总资产为 1806024041.000.

什么是企业年收入？

年收入为 N/A.

企业利润率是多少？

公司利润率为 0.715.

什么是公司自由现金流？

自由现金流为 -0.334.

什么是企业净利润率？

净利润率为 0.282.

企业总收入是多少？

总收入为 0.306.

什么是 Nanjing Vishee Medical Technology Co., Ltd (688580.SS) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 136258629.000.

公司总债务是多少？

债务总额为 0.000.

营业费用是多少？

运营支出为 208672734.000.

公司现金是多少？

企业现金为 0.000.